Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

5.84
Delayed Data
As of Feb 11
 -0.07 / -1.18%
Today’s Change
4.00
Today|||52-Week Range
8.48
-25.79%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close5.91
Today’s open5.75
Day’s range5.62 - 5.97
Volume158,432
Average volume (3 months)394,602
Market cap$356.7M
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-121.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+31.00%
P/E ratioNM
Price/Sales2.68
Price/Book5.89

Competitors

 Today’s
change
Today’s
% change
RDNTRadNet Inc-0.33-6.15%
GNMKGenMark Diagnostics ...+0.08+1.61%
NVTAInvitae Corp+0.60+10.08%
CPHRCipher Pharmaceutica...-0.06-1.64%
Data as of 4:02pm ET, 02/11/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$87.1M
Annual profit (last year)$1.1M
Net profit margin1.30%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers